Literature DB >> 12069822

Regulation of neuronal cytoskeleton by lysophosphatidic acid: role of GSK-3.

C L Sayas1, J Avila, F Wandosell.   

Abstract

Neurite retraction is a crucial process during nervous system development and neurodegeneration. This process implies reorganization of the neuronal cytoskeleton. Some bioactive lipids such as lysophosphatidic acid (LPA) induce neurite retraction. The reorganization of the actin cytoskeleton during neurite retraction is one of the best-characterized effects of LPA. However, less information is available regarding the reorganization of the microtubule (MT) network in response to LPA in neuronal cells. Here, we first give an overview of the roles of cytoskeleton during neurite outgrowth, and subsequently, we review some of the data from different laboratories concerning LPA-induced cytoskeletal rearrangement in neuronal cells. We also summarize our own recent results about modifications of MTs during LPA-induced neurite retraction. We have shown that LPA induces changes in tubulin pools and increases in the phosphorylation levels of microtubule-associated proteins (MAPs), such as Tau. Tau hyperphosphorylation in response to LPA is mediated by the activation of glycogen synthase kinase-3 (GSK-3). The upregulation of GSK-3 activity by LPA seems to be a general process as it occurs in diverse neuronal cells of different species in correlation with the neurite retraction process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069822     DOI: 10.1016/s1388-1981(02)00149-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

1.  Dynamics of outgrowth in a continuum model of neurite elongation.

Authors:  Bruce P Graham; Karen Lauchlan; Douglas R Mclean
Journal:  J Comput Neurosci       Date:  2006-02-20       Impact factor: 1.621

Review 2.  Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions.

Authors:  Richard S Jope; Myoung-Sun Roh
Journal:  Curr Drug Targets       Date:  2006-11       Impact factor: 3.465

3.  Lysophosphatidic acid induces neurite retraction in differentiated neuroblastoma cells via GSK-3β activation.

Authors:  Yuanjie Sun; Nam-Ho Kim; Haijie Yang; Seung-Hyuk Kim; Sung-Oh Huh
Journal:  Mol Cells       Date:  2011-04-14       Impact factor: 5.034

4.  P2X7 nucleotide receptor is coupled to GSK-3 inhibition and neuroprotection in cerebellar granule neurons.

Authors:  Felipe Ortega; Raquel Pérez-Sen; Esmerilda G Delicado; M Teresa Miras-Portugal
Journal:  Neurotox Res       Date:  2009-02-24       Impact factor: 3.911

5.  Lysophosphatidic acid can support the formation of membranous structures and an increase in MBP mRNA levels in differentiating oligodendrocytes.

Authors:  Luciana Nogaroli; Larra M Yuelling; Jameel Dennis; Karen Gorse; Shawn G Payne; Babette Fuss
Journal:  Neurochem Res       Date:  2008-07-02       Impact factor: 3.996

6.  Inhibition of cyclin-dependent kinase 5 but not of glycogen synthase kinase 3-β prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T-cell leukemia virus type I-infected lymphocytes.

Authors:  Horacio Maldonado; Eugenio Ramírez; Elias Utreras; María E Pando; Ana M Kettlun; Mario Chiong; Ashok B Kulkarni; Lucía Collados; Javier Puente; Luis Cartier; María A Valenzuela
Journal:  J Neurosci Res       Date:  2011-06-10       Impact factor: 4.164

7.  Spatial phosphoprotein profiling reveals a compartmentalized extracellular signal-regulated kinase switch governing neurite growth and retraction.

Authors:  Yingchun Wang; Feng Yang; Yi Fu; Xiahe Huang; Wei Wang; Xinning Jiang; Marina A Gritsenko; Rui Zhao; Matthew E Monore; Olivier C Pertz; Samuel O Purvine; Daniel J Orton; Jon M Jacobs; David G Camp; Richard D Smith; Richard L Klemke
Journal:  J Biol Chem       Date:  2011-03-28       Impact factor: 5.157

Review 8.  Crosstalk between WIP and Rho family GTPases.

Authors:  Inés M Antón; Carla Gómez-Oro; Sergio Rivas; Francisco Wandosell
Journal:  Small GTPases       Date:  2018-01-29

9.  Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau.

Authors:  Mohammad Arif; Jianshe Wei; Qi Zhang; Fei Liu; Gustavo Basurto-Islas; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  J Biol Chem       Date:  2014-08-15       Impact factor: 5.157

10.  GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction.

Authors:  C Laura Sayas; Aafke Ariaens; Bas Ponsioen; Wouter H Moolenaar
Journal:  Mol Biol Cell       Date:  2006-02-01       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.